FTO upregulated the MYC level, known as proto-oncogene TF [26], and downregulated the expression of MAX interactor 1 (MXI1), which binds to the MYC promoter and inhibits its expression, playing an oncosuppressor role in glioblastoma [27,28]. The gene discussed is FTO; the disease is glioblastoma.